The total return over the past 12 months is -62.41% vs. +16.94% for the S&P 500. So far it's up -62.97% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (62.41%) | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | (62.41%) | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | (73.64%) | (38.74%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
aTyr Pharma, Inc. (ATYR)
| Year | Start price | End price | ATYR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.78 | $0.29 | (62.97%) | +14.51% | (77.48%) |
| 2025 | $3.62 | $0.78 | (78.37%) | +17.72% | (96.09%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
